Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 426

1.

The Contribution of Drugs and Helicobacter pylori to Gastric Mucosa Changes in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome.

Reshetnyak TM, Doroshkevich IA, Seredavkina NV, Nasonov EL, Maev IV, Reshetnyak VI.

Int J Rheumatol. 2019 May 5;2019:9698086. doi: 10.1155/2019/9698086. eCollection 2019.

2.

The use of Tofacitinib in the treatment of inflammatory bowel disease.

Nasonov EL, Abdulganieva DI, Fairushina IF.

Ter Arkh. 2019 Mar 18;91(2):101-108. doi: 10.26442/00403660.2019.02.000155. Review.

PMID:
31094180
3.

[Cognitive disorders in Behçet's disease].

Ovcharov PS, Lisitsyna TA, Veltishchev DY, Burenchev DV, Ishchenko DA, Seravina OF, Kovalevskaya OB, Alekberova ZS, Nasonov EL.

Zh Nevrol Psikhiatr Im S S Korsakova. 2019;119(2):11-17. doi: 10.17116/jnevro201911902111. Russian.

PMID:
30874520
4.

Comparative analysis of anxiety-depressive spectrum disorders in patients with rheumatic diseases.

Lisitsyna TA, Veltishchev DY, Seravina OF, Kovalevskaya OB, Starovoytova MN, Desinova OV, Abramkin AA, Ovcharov PS, Vasil'ev VI, Alekberova ZS, Krasnov VN, Nasonov EL.

Ter Arkh. 2018 May 11;90(5):30-37. doi: 10.26442/terarkh201890530-37.

PMID:
30701894
5.

Efficacy and tolerability of abatacept treatment: results of 12 months observation.

Borisova MA, Lukina GV, Sigidin YA, Aronova ES, Luchihina EL, Karateev DE, Glukhova SV, Nasonov EL.

Ter Arkh. 2018 May 11;90(5):44-49. doi: 10.26442/terarkh201890544-49.

PMID:
30701888
6.

Association of polymorphisms of HLA-DRB1 and TNF-308 G/A with radiographic joint damage in patients with early rheumatoid arthritis with high inflammatory activity, treated according to the principle of "Treat to target" (REMARKA study).

Guseva IA, Smirnov AV, Demidova NV, Krylov MY, Avdeeva AS, Samarkina EY, Luchikhina EL, Karateev DE, Abramov DD, Nasonov EL.

Ter Arkh. 2018 May 11;90(5):38-43. doi: 10.26442/terarkh201890538-43.

PMID:
30701887
7.

Results of one-year treat-to-target strategy in early psoriatic arthritis: data of an open-label REMARCA study.

Korotaeva TV, Loginova EY, Getiya TS, Nasonov EL.

Ter Arkh. 2018 May 11;90(5):22-29. doi: 10.26442/terarkh201890522-29.

PMID:
30701886
8.

Atherosclerosis: perspectives of anti-inflammatory therapy.

Nasonov EL, Popkova TV.

Ter Arkh. 2018 May 11;90(5):4-12. doi: 10.26442/terarkh201890514-12. Review.

PMID:
30701884
9.

Imatinib mesylate use in refractory eosinophilic granulomatosis with polyangiitis: a literature review and a case report.

Beketova TV, Volkov MY, Naryshkin EA, Novoselova TM, Nasonov EL.

Clin Rheumatol. 2018 Jun;37(6):1729-1735. doi: 10.1007/s10067-018-4018-1. Epub 2018 Mar 21. Review.

PMID:
29564565
10.

Calcification of coronary arteries in early rheumatoid arthritis prior to anti-rheumatic therapy.

Udachkina HV, Novikova DS, Popkova TV, Kirillova IG, Markelova EI, Luchikhina EL, Lukina GV, Sinitsyn VE, Karateev DE, Nasonov EL.

Rheumatol Int. 2018 Feb;38(2):211-217. doi: 10.1007/s00296-017-3860-9. Epub 2017 Oct 27.

PMID:
29079928
11.

[Chronic thromboembolic pulmonary hypertension developed in a female patient with lupus erythematosus and secondary antiphospholipid syndrome].

Movsisyan GA, Martynyuk TV, Mershin KV, Danilov NM, Satybaldyeva MA, Reshetnyak TM, Akchurin RS, Nasonov EL, Chazova IY.

Ter Arkh. 2017;89(9):93-99. doi: 10.17116/terarkh201789993-99. Russian.

PMID:
29039836
12.

[Independent risk factors for severe cardiovascular events in male patients with gout: Results of a 7-year prospective study].

Eliseev MS, Denisov IS, Markelova EI, Glukhova SI, Nasonov EL.

Ter Arkh. 2017;89(5):10-19. doi: 10.17116/terarkh201789510-19. Russian.

PMID:
28631693
13.

Maintenance of remission with combination etanercept-DMARD therapy versus DMARDs alone in active rheumatoid arthritis: results of an international treat-to-target study conducted in regions with limited biologic access.

Pavelka K, Akkoç N, Al-Maini M, Zerbini CAF, Karateev DE, Nasonov EL, Rahman MU, Pedersen R, Dinh A, Shen Q, Vasilescu R, Kotak S, Mahgoub E, Vlahos B.

Rheumatol Int. 2017 Sep;37(9):1469-1479. doi: 10.1007/s00296-017-3749-7. Epub 2017 Jun 9.

PMID:
28597306
14.

[Cardiovascular Complications of Rheumatoid Arthritis: Prevalence and Pathogenesis].

Krougly LB, Fomicheva OA, Karpov YA, Popkova TV, Novikova DS, Nasonov EL.

Kardiologiia. 2016 Jun;56(6):89-95. Review. Russian.

PMID:
28290854
15.
16.

[Prospects for rheumatoid arthritis pharmacotherapy: New opportunities and recommendations].

Nasonov EL.

Ter Arkh. 2016;88(12):4-10. doi: 10.17116/terarkh201688124-10. Russian.

PMID:
28139553
17.

[Interleukin-6 inhibition and cardiovascular disease in patients with rheumatoid arthritis].

Popkova TV, Novikova DS, Nasonov EL.

Ter Arkh. 2016;88(5):93-101. doi: 10.17116/terarkh201688593-101. Review. Russian.

PMID:
27458623
18.

[Cardiovascular disease in rheumatic diseases].

Nasonov EL, Popkova TV, Novikova DS.

Ter Arkh. 2016;88(5):4-12. doi: 10.17116/terarkh20168854-12. Review. Russian.

PMID:
27458622
19.

[Current approaches to diagnosing and treating eosinophilic granulomatosis with polyangiitis: The 2015 international guidelines].

Beketova TV, Volkov MY, Nasonov EL.

Ter Arkh. 2016;88(5):86-92. doi: 10.17116/terarkh201688586-92. Review. Russian.

PMID:
27239934
20.

[N-terminal pro-brain natriuretic peptide levels and diastolic dysfunction in patients with early rheumatoid arthritis before the administration of disease-modifying antirheumatic drugs].

Kirillova IG, Novikova DS, Popkova TV, Aleksandrova EN, Novikov AA, Gorbunova YN, Markelova EI, Korsakova YO, Glukhova SI, Volkov AV, Luchikhina EL, Demidova NV, Kasumova KA, Vladimirov SA, Kanonirova MA, Lukina GL, Karateev DE, Nasonov EL.

Ter Arkh. 2016;88(5):19-26. doi: 10.17116/terarkh201688519-26. Russian.

PMID:
27239922

Supplemental Content

Loading ...
Support Center